Does RISANKIZUMAB-RZAA Cause Incorrect dose administered? 330 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 330 reports of Incorrect dose administered have been filed in association with RISANKIZUMAB-RZAA. This represents 0.5% of all adverse event reports for RISANKIZUMAB-RZAA.
330
Reports of Incorrect dose administered with RISANKIZUMAB-RZAA
0.5%
of all RISANKIZUMAB-RZAA reports
0
Deaths
30
Hospitalizations
How Dangerous Is Incorrect dose administered From RISANKIZUMAB-RZAA?
Of the 330 reports, 30 (9.1%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Incorrect dose administered Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 330 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Incorrect dose administered?
TIRZEPATIDE (23,301)
ADALIMUMAB (14,000)
DUPILUMAB (9,907)
RANITIDINE (9,337)
INSULIN LISPRO (8,318)
ACETAMINOPHEN (5,316)
DULAGLUTIDE (5,207)
SECUKINUMAB (4,524)
INSULIN GLARGINE (3,070)
SOMATROPIN (2,772)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Incorrect dose administered Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA